Dasatinib

Description

Dasatinib is an anticancer medicine used to treat certain types of blood cancer. It blocks the action of an abnormal protein that signals cancer cells to multiply. Thus, it stops the cancer cells from spreading. Dasatinib may cause some side effects like diarrhoea, vomiting, stomach pain, nausea, fever, fatigue, weakness, headache, dizziness, rash, etc. Consult your doctor if these side effects persist or become severe. Avoid taking this medicine if you are allergic to it. Dasatinib can be taken with or without food. Take it in the dose and duration prescribed by your doctor. Avoid taking more than the recommended dose as it may increase the risk of undesired effects. Take it every day at the same time to maintain a consistent level of this medicine in your blood. Do not discontinue this medication without consulting your doctor, as it may worsen your condition. Dasatinib may not be suitable for everyone. It is not recommended for use in children weighing less than 10 kg. Inform your doctor if you have heart, liver, or kidney problems or any other health conditions to make sure it is safe for you. Also, inform your doctor about all your ongoing medications to avoid undesired effects. Dasatinib is unsafe for use during pregnancy as it can harm the unborn baby. Consult your doctor if you are breastfeeding.

Side effects

Major & minor side effects for Dasatinib

  • Body aches or Pain
  • Burning, numbness, tingling in the arms and feet
  • Chest pain
  • Chills
  • Cough
  • Dizziness
  • Headache
  • Weight gain
  • Fever
  • Sore throat
  • Ulcers or white spots in the mouth
  • Nausea
  • Irregular breathing
  • Increased sweating
  • Diarrhoea
  • Stomach pain
  • Skin Rash

Uses of Dasatinib

What is it prescribed for?

  • Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML)
  • Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL)
Read More
Concerns

Commonly asked questions

  • Onset of action
    The amount of time taken by Dasatinib to show its effect is not clinically established.
  • Duration of effect
    The amount of time for which Dasatinib remains effective in your body is not clinically established.
  • Safe with alcohol?
    Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
  • Is it habit forming?
    No habit-forming tendencies were reported for Dasatinib.
  • Usage in pregnancy?
    Dasatinib is unsafe for use during pregnancy as it can harm your developing foetus. Hence, consult your doctor if you are pregnant.
  • Usage while breast-feeding?
    Due to the lack of relevant safety information, Dasatinib is not recommended for use while breastfeeding. Consult your doctor if you are breastfeeding.

Allergy

Avoid taking Dasatinib if you are allergic to it. Seek immediate medical attention if you notice any symptoms such as skin rash, itching/swelling (especially of the face/tongue/throat), severe dizziness, breathing difficulty, etc.
Warnings for special population

Pregnancy

Dasatinib is unsafe for use during pregnancy as it can harm your developing foetus. Hence, consult your doctor if you are pregnant.

Breast-feeding

Due to the lack of relevant safety information, Dasatinib is not recommended for use while breastfeeding. Consult your doctor if you are breastfeeding.
General warnings

Driving or operating machines

Dasatinib may cause dizziness or blurred vision. Hence, avoid performing activities that require mental alertness, such as driving vehicles or operating machines, if you experience such symptoms.

Bonemarrow suppression

Bone marrow suppression is a condition in which your bone marrow (a spongy substance found in most bones that produces blood cells) activity is reduced which further leads to a decrease in blood cell count. If you are diagnosed with such a condition, Dasatinib should be used with caution as it may further worsen your condition.

Internal bleeding or hemorrhage

Dasatinib should be used with caution due to the increased risk of internal bleeding or haemorrhages. Inform your doctor if you experience symptoms like unusual bleeding or bruising, black or tarry stools, vomiting up blood, etc.

Risk of infections

Dasatinib may weaken your immune system and make you more vulnerable to infections. Hence, avoid coming in contact with people having infections while taking this medicine.

Pulmonary arterial hypertension (PAH)

Pulmonary arterial hypertension refers to high blood pressure in the arteries of the lungs. Dasatinib should be used with caution as it may cause pulmonary arterial hypertension. Consult your doctor immediately if you experience breathing difficulty or fatigue.

Missed Dose

Take the missed dose of Dasatinib as soon as you remember. Skip the missed dose if it is time for your next scheduled dose. Do not use extra medicine to make up for the missed dose.

Overdose

Never take more than the prescribed dose of Dasatinib. Seek emergency medical treatment in case of an overdose for further guidance.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

Instructions

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
Interaction with Medicine

BCG vaccine

Adalimumab

Alteplase

Dabigatran

Cisapride

Diclofenac

Disease interactions

Cardiovascular disease

Use of Dasatinib may cause QT prolongation (a condition in which your heart muscles take a longer time to recharge between a heartbeat). Hence, it should be used with caution if you have heart problems or taking other medications that are known to cause QT prolongation. If you have low blood potassium or magnesium levels, it may further worsen your condition.

Fluid retention

Dasatinib should be used with caution as it may cause fluid retention (abnormal build-up of fluid in the body). Your doctor may adjust the dose based on your clinical condition.

Hepatic impairment

Dasatinib should be used with caution if you have liver problems as it may worsen your condition.
Food interactions
Grapefruit juice can significantly increase the blood levels of Dasatinib. Hence consumption of grapefruit juice is not recommended during treatment with this medicine due to the increased risk of severe side effects. Consult your doctor if you experience palpitation, sore throat, unusual bleeding, paleness, fatigue, fever, chills, weight loss, pain or burning during urination, body sores, muscle pain, etc.
Lab interactions
Information not available.
Take Dasatinib exactly as prescribed by your doctor. Do not break, chew, or crush the tablet. Swallow as a whole with a sufficient amount of water. Do not take in larger or smaller amounts than prescribed. Consult your doctor if you experience any undesirable effects that persist or worsen. Women of childbearing potential should use effective contraception during treatment with this medicine to avoid becoming pregnant. Dasatinib may increase your risk of severe bleeding, especially if you are taking a blood thinner or any medication to prevent blood clots. Dasatinib may weaken your immune system and increase the risk of infections. Avoid coming in contact with people who are sick or have infections. Avoid consuming grapefruit juice during treatment with this medicine as it may increase the risk of undesired effects.
Miscelleneous

Can be taken with or without food, as advised by your doctor

To be taken as instructed by doctor

Does not cause sleepiness

How it works
Dasatinib works by inhibiting the actions of an abnormal protein that cause the cancer cells to multiply. This helps in stopping the growth and spread of cancer.
Legal Status

Approved

Approved

Approved

Approved

Classification

Category

BCR-ABL tyrosine kinase inhibitors, Anticancer drug

Schedule

Schedule H

Drugs, H., 2022. Dasatinib: MedlinePlus Drug Information. [online] Medlineplus.gov. Available at: < [Accessed 2 March 2022].

https://medlineplus.gov/druginfo/meds/a607063.html>

Medicines.org.uk. 2022. Dasatinib Zentiva 50 mg film-coated tablets - Patient Information Leaflet (PIL) - (emc). [online] Available at: < [Accessed 2 March 2022].

https://www.medicines.org.uk/emc/product/10918/pil>

How will this medicine affect me?

Consult top doctors online and get an answer now
Consult now
Consult now

Looking for a doctor?

Book an appointment with the top doctors near you
Book now
Book now
Something doesn’t feel right?
Report an error

Information on this page was last updated on 2 Mar 2022

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.